0001104659-18-054173.txt : 20180829
0001104659-18-054173.hdr.sgml : 20180829
20180829172218
ACCESSION NUMBER: 0001104659-18-054173
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180827
FILED AS OF DATE: 20180829
DATE AS OF CHANGE: 20180829
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hoffman Michael B
CENTRAL INDEX KEY: 0001290208
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36020
FILM NUMBER: 181045000
BUSINESS ADDRESS:
BUSINESS PHONE: (203) 413-2200
MAIL ADDRESS:
STREET 1: 1 GREENWICH OFFICE PARK
CITY: GREENWICH
STATE: CT
ZIP: 06831
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Onconova Therapeutics, Inc.
CENTRAL INDEX KEY: 0001130598
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
BUSINESS PHONE: 267-759-3681
MAIL ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
FORMER COMPANY:
FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20090526
FORMER COMPANY:
FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS INC
DATE OF NAME CHANGE: 20001226
4
1
a4.xml
4
X0306
4
2018-08-27
0
0001130598
Onconova Therapeutics, Inc.
ONTX
0001290208
Hoffman Michael B
53 EAST 83 STREET
NEW YORK
NY
10028
1
0
0
0
Common Stock
2018-08-27
4
S
0
20000
0.4535
D
5811116
I
By the Michael and Jane Hoffman 2018 Descendants Trust
Common Stock
2018-08-28
4
S
0
20000
0.4445
D
5791116
I
By the Michael and Jane Hoffman 2018 Descendants Trust
Common Stock
2018-08-28
4
S
0
30000
0.4569
D
5761116
I
By the Michael and Jane Hoffman 2018 Descendants Trust
Common Stock
2018-08-29
4
S
0
29999.262
0.4507
D
5731116.738
I
By the Michael and Jane Hoffman 2018 Descendants Trust
These shares are held for the benefit of the reporting person's descendants. The reporting person's spouse is a trustee of the trust. The reporting person is a general agent of the trust.
Includes (i) 19,951 options to purchase shares of Common Stock of the Issuer, which are immediately exercisable or will be exercisable within 60 days of the date hereof; (ii) 5,700,836.738 shares of Common Stock held by the Michael and Jane Hoffman 2018 Descendants Trust, of which Mr. Hoffman is donor (which includes 2,211,765 shares of Common Stock issuable upon the exercise of warrants for 55,294.125 shares of Series B Preferred Stock that convert into shares of Common Stock and 396,633 shares of Common Stock issuable upon the exercise of warrants, all of which are immediately exercisable or exercisable within 60 days hereof); and (iii) 8,453 shares of Common Stock held by the Michael and Jane Hoffman 2013 Descendants Trust (Non-GST Exempt Trust), of which Mr. Hoffman is donor.
/s/ Mark Guerin as attorney-in-fact
2018-08-29